Kevin J. Ballinger, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 58,128 shares at $26.18 ($1.5M) on 2017-05-17, disclosed to the SEC on 2017-05-18.
Open-market sale of $1.5M BSX by EVP & President, Interven Cardio. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 400 | $0 | 0.0% |
| 2 | $26.09 | 12,776 | $333K | 22.1% |
| 3 | $26.09 | 12,776 | $333K | 22.1% |
| 4 | $26.18 | 16,088 | $421K | 27.9% |
| 5 | $26.18 | 16,088 | $421K | 27.9% |
| Total | $25.96 avg | 58,128 |
| $1.5M |
| 100% |
| Filing → |
| BSX | SELL | 2020-03-03 | $1.2M | — | Filing → |
| BSX | SELL | 2020-02-26 | $466K | — | Filing → |
| BSX | SELL | 2020-02-19 | $149K | — | Filing → |